Earnings Feed
Start Free
Home/Filings/4/0001209191-21-056523
4//SEC Filing

Timothy Lu 4

Accession 0001209191-21-056523

CIK 0001645569other
View on SEC.govCompany Profile

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 9:24 PM ET

Size

14.0 KB

Accession

0001209191-21-056523

Insider Transaction Report

Form 4
Period: 2021-09-14
DICE Therapeutics, Inc.DICE
Timothy Lu
CMO
Transactions
  • Award

    Stock Option (right to buy)

    2021-09-14+25,593→ 25,593 total
    Exercise: $17.00Exp: 2031-09-14→ Common Stock (25,593 underlying)
  • Award

    Stock Option (right to buy)

    2021-09-14+25,817→ 25,817 total
    Exercise: $17.00Exp: 2031-09-14→ Common Stock (25,817 underlying)
  • Award

    Stock Option (right to buy)

    2021-09-14+17,350→ 17,350 total
    Exercise: $17.00Exp: 2031-09-14→ Common Stock (17,350 underlying)
  • Award

    Stock Option (right to buy)

    2021-09-14+31,304→ 31,304 total
    Exercise: $17.00Exp: 2031-09-14→ Common Stock (31,304 underlying)
Holdings

  • Common Stock

    162,285
Footnotes (5)
  • [F1]The number of shares of Common Stock reported in the Reporting Holder's Form 3 reflected the conversion of derivative securities based on the midpoint of the Issuer's initial public offering range of $16.00 per share. The number of shares of Common Stock reflected in this Form 4 reflects the adjusted number of shares issued based on the higher initial public offering price of $17.00 per share, and does not reflect a disposition of shares.
  • [F2]Certain of the shares are subject to the Issuer's right of repurchase if underlying vesting conditions are not met.
  • [F3]The option vests as to 1/4 of the total shares on August 24, 2020, and then 1/48th of the total shares vest monthly, subject to the Reporting Holder's continuing employment with the Registrant.
  • [F4]The option vests as to 1/48th of the total shares monthly, beginning January 1, 2021, subject to the Reporting Holder's continuing employment with the Registrant.
  • [F5]The option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continuing employment with the Registrant.

Documents

1 file

Issuer

DICE Therapeutics, Inc.

CIK 0001645569

→
Entity typeother

Related Parties

1
  • filerCIK 0001880973

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 9:24 PM ET
Size
14.0 KB
View on SEC.gov